Open access · CC-BY
via OpenAlex
The Effects of SIRT1 on Alzheimer's Disease Models
International Journal of Alzheimer s Disease · 2012 · ▲ 38 citations
Abstract
Sirtuins are highly conserved NAD(+)-dependent enzymes that were shown to have beneficial effects against age-related diseases. Aging is the major risk factor for all neurodegenerative disorders including Alzheimer's Disease (AD). Sirtuins have been widely studied in the context of AD using different mouse models. In most of these studies, overexpression of SIRT1 has been shown to have protective effects against AD. Therefore, designing therapeutics based on increasing SIRT1 activity might be important for investigating the ways of treatment for this disease. This paper summarizes the recent research on the effect of SIRT1 in AD animal models and also the potential of SIRT1 being a therapeutical target for AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2012/509529
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Dönmez, G. (2012). The Effects of SIRT1 on Alzheimer's Disease Models. <em>International Journal of Alzheimer s Disease</em>. https://doi.org/10.1155/2012/509529
Vancouver
Dönmez G. The Effects of SIRT1 on Alzheimer's Disease Models. International Journal of Alzheimer s Disease. 2012. doi:10.1155/2012/509529.
BibTeX
@article{gizem2012TheEff,
title = {The Effects of SIRT1 on Alzheimer's Disease Models},
author = {Gizem Dönmez},
journal = {International Journal of Alzheimer s Disease},
year = {2012},
doi = {10.1155/2012/509529},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes & Metabolism Journal 2013
Open access · CC-BY
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Current Opinion in Psychiatry 2012
Citation only
Sirtuins in cognitive ageing and Alzheimer's disease
Medical Science Monitor 2011
Open access · CC-BY
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Journal of Neurochemistry 2007
Open access · OA
GABAAreceptors in aging and Alzheimer’s disease
Frontiers in Pharmacology 2014
Open access · CC-BY
Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
European Journal of Medicinal Chemistry 2021
Citation only